Literature DB >> 25449044

The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).

Claustre Pont-Sunyer1, Anna Hotter, Carles Gaig, Klaus Seppi, Yaroslau Compta, Regina Katzenschlager, Natalia Mas, Dominik Hofeneder, Thomas Brücke, Angels Bayés, Karoline Wenzel, Jon Infante, Heidemarie Zach, Walter Pirker, Ignacio J Posada, Ramiro Álvarez, Lourdes Ispierto, Oriol De Fàbregues, Antoni Callén, Antoni Palasí, Miquel Aguilar, Maria José Martí, Francesc Valldeoriola, Manel Salamero, Werner Poewe, Eduardo Tolosa.   

Abstract

Nonmotor symptoms (NMS) in Parkinson's disease (PD) can precede onset of motor symptoms. Relationship between premotor symptoms onset and motor features is limited. Our aim is to describe the presence and perceived onset of NMS in PD as well as their possible association with motor phenotype. Presence and onset of NMS were assessed by a custom-made questionnaire in 109 newly diagnosed untreated PD patients and 107 controls from 11 Spanish and Austrian centers. Seventeen of thirty-one NMS were more common in patients than controls (P < 0.05). They were usually mild and frequently reported to occur at different time-spans before motor symptoms. Anhedonia, apathy, memory complaints, and inattention occurred more frequently during the 2-year premotor period. Those reported more frequently in the 2- to 10-year premotor period were smell loss, mood disturbances, taste loss, excessive sweating, fatigue, and pain. Constipation, dream-enacting behavior, excessive daytime sleepiness, and postprandial fullness were frequently perceived more than 10 years before motor symptoms. No correlation between NMS burden and motor severity, age, or gender was observed. NMS associated in four clusters: rapid eye movement sleep behavior disorder symptoms-constipation, cognition-related, mood-related, and sensory clusters. No cluster was associated with a specific motor phenotype or severity. NMS are common in early unmedicated PD and frequently reported to occur in the premotor period. They are generally mild, but a patient subgroup showed high NMS burden mainly resulting from cognition-related symptoms. Certain NMS when present at the time of assessment or in the premotor stage, either alone or in combination, allowed discriminating PD from controls.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; nonmotor symptoms; premotor phase

Mesh:

Year:  2014        PMID: 25449044     DOI: 10.1002/mds.26077

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  139 in total

Review 1.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Authors:  Benzi M Kluger; Karen Herlofson; Kelvin L Chou; Jau-Shin Lou; Christopher G Goetz; Anthony E Lang; Daniel Weintraub; Joseph Friedman
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

Review 3.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 4.  Parkinson's disease as a multisystem disorder.

Authors:  Lisa Klingelhoefer; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2017-02-02       Impact factor: 3.575

5.  Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.

Authors:  Carla Masala; Paolo Solla; A Liscia; G Defazio; L Saba; A Cannas; A Cavazzana; T Hummel; A Haehner
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

6.  Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.

Authors:  Indrani Datta; S R Mekha; Alka Kaushal; Kavina Ganapathy; Rema Razdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-29       Impact factor: 3.000

Review 7.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

8.  Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.

Authors:  Young-Ju Kim; Chang-Min Lee; Seongheon Kim; Jae-Won Jang; Seo-Young Lee; Seung-Hwan Lee
Journal:  J Neurol       Date:  2019-11-05       Impact factor: 4.849

Review 9.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 10.  Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.

Authors:  S L Sison; S C Vermilyea; M E Emborg; A D Ebert
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-04       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.